Lisa Conroy

Lisa Conroy is the Director of Communications at Antidote. She is a seasoned health communications strategist dedicated to understanding the reasons people make the health choices they do, and determining what that means in terms of how scientific data should be communicated. Prior to her role at Antidote, Lisa ran the TEDMED Great Challenges program, a public health initiative funded by RWJF. She also has experience working in pharmaceutical public relations in the areas of respiratory diseases, oncology, and HIV. Lisa holds an MPH from Columbia and a BA in English and International Studies from Northwestern.

Press release: "Antidote Technologies and the National Minority Health Association Collaborate to Increase Diversity in Clinical Trial Recruitment"

Press Release: "Antidote Wins 2021 WEGO Health Award for 'Most Valuable Patient Support or Access Program'"

Business Insider: "Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology."

Press release: "Antidote Technologies’ Business Development Leader Dave Mauro Named to the 2021 PharmaVOICE 100"

Vator News: "Today's entrepreneur: Laurent Schockmel, CEO of Antidote"

Vator News: "Antidote raises $23M to match patients with clinical trials"

Press release: "Antidote Raises $23 Million to Scale Digital Patient Engagement Services"

Press Release: "Antidote Technologies Registers Over 40,000 COPD Patients for Clinical Trial Matching Services"

Press release: "Antidote Technologies Drives Patient Recruitment for Three Pivotal COVID-19 Clinical Trials"

Press release: "Antidote Technologies Spearheads Recruitment for a COVID Early Treatment Fund Clinical Trial Recently Featured on CBS Program 60 Minutes"